Vera Therapeutics Inc
NASDAQ:VERA
Balance Sheet
Balance Sheet Decomposition
Vera Therapeutics Inc
Current Assets | 416.4m |
Cash & Short-Term Investments | 738.2m |
Other Current Assets | -321.9m |
Non-Current Assets | 3m |
PP&E | 2.5m |
Other Non-Current Assets | 473k |
Current Liabilities | 14.5m |
Accounts Payable | 5.2m |
Accrued Liabilities | 9.3m |
Non-Current Liabilities | 51.3m |
Long-Term Debt | 50.1m |
Other Non-Current Liabilities | 1.2m |
Balance Sheet
Vera Therapeutics Inc
Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|
Assets | ||||||
Cash & Cash Equivalents |
3
|
54
|
80
|
44
|
161
|
|
Cash Equivalents |
3
|
54
|
80
|
44
|
161
|
|
Short-Term Investments |
0
|
0
|
0
|
71
|
115
|
|
Total Receivables |
0
|
0
|
0
|
0
|
0
|
|
Other Current Assets |
0
|
1
|
3
|
11
|
11
|
|
Total Current Assets |
4
|
54
|
83
|
126
|
172
|
|
PP&E Net |
1
|
0
|
0
|
5
|
3
|
|
PP&E Gross |
1
|
0
|
0
|
0
|
0
|
|
Accumulated Depreciation |
1
|
0
|
0
|
0
|
0
|
|
Long-Term Investments |
0
|
0
|
1
|
0
|
0
|
|
Other Long-Term Assets |
0
|
0
|
0
|
1
|
0
|
|
Total Assets |
5
N/A
|
55
+911%
|
84
+53%
|
131
+57%
|
176
+34%
|
|
Liabilities | ||||||
Accounts Payable |
0
|
1
|
1
|
12
|
11
|
|
Accrued Liabilities |
0
|
1
|
6
|
14
|
11
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
0
|
1
|
0
|
0
|
0
|
|
Total Current Liabilities |
1
|
2
|
8
|
26
|
22
|
|
Long-Term Debt |
0
|
0
|
5
|
25
|
50
|
|
Other Liabilities |
1
|
2
|
2
|
4
|
2
|
|
Total Liabilities |
2
N/A
|
4
+139%
|
14
+230%
|
55
+284%
|
74
+36%
|
|
Equity | ||||||
Common Stock |
40
|
140
|
0
|
0
|
0
|
|
Retained Earnings |
38
|
91
|
124
|
213
|
309
|
|
Additional Paid In Capital |
2
|
2
|
194
|
290
|
411
|
|
Total Equity |
4
N/A
|
50
+1 334%
|
70
+39%
|
77
+10%
|
102
+32%
|
|
Total Liabilities & Equity |
5
N/A
|
55
+911%
|
84
+53%
|
131
+57%
|
176
+34%
|
|
Shares Outstanding | ||||||
Common Shares Outstanding |
21
|
21
|
21
|
28
|
44
|